STERIS Aktie

212,12USD -3,86USD -1,79%
STERIS für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2PGLV / ISIN: IE00BFY8C754

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2022 2023 2024 2025 2026
Personal am Ende des Jahres 16 422 17 000 18 179 17 787 0
Umsatz pro Mitarbeiter in Mio. EUR 0,28 0,29 0,28 0,31 0,00

Bilanz (in Mio. USD) - Aktiva

2022 2023 2024 2025 2026
Summe Umlaufvermögen 1 879 2 011 2 869 2 001 2 395
Summe Anlagevermögen 9 545 8 810 8 195 8 146 8 343
Summe Aktiva 11 424 10 822 11 064 10 147 10 737

Bilanz (in Mio. USD) - Passiva

2022 2023 2024 2025 2026
Summe Fremdkapital 4 879 4 735 4 748 3 531 3 540
Summe Eigenkapital 6 545 6 087 6 315 6 616 7 197
Summe Passiva 11 424 10 822 11 064 10 147 10 737

Adresse

70 Sir John Rogerson's Quay, 2 Dublin
Internet http://www.steris.com

Management

Bill Brodbeck
Vice President-Regulatory Affairs
Cary L. Majors
Senior Vice President & President-Healthcare
Christopher S. Holland
Independent Director
Cynthia L. Feldmann
Independent Director
Daniel A. Carestio
President, Chief Executive Officer & Director
Esther M. Alegria
Independent Director
John Adam Zangerle
Secretary, Senior Vice President & General Counsel
Julie Winter
VP-Investor Relations & Corporate Communications
Karen L. Burton
Chief Financial Officer & Senior Vice President
Laura Weien
Vice President & Chief Compliance Officer
Louis A. Shapiro
Independent Director
Mary Clare Fraser
Chief Human Resources Officer & Senior VP
Mohsen M. Sohi
Chairman
Nirav R. Shah
Independent Director
Paul E. Martin
Independent Director
Pierre Boulud
Director
Renato G. Tamaro
Treasurer & Vice President
Richard Carroll Breeden
Independent Director
Walter M. Rosebrough
Chief Executive Officer-Emeritus